Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2012 (2012), Article ID 364534, 4 pages
http://dx.doi.org/10.1155/2012/364534
Review Article

Lipopolysaccharide-Induced Cellular Activation May Participate in the Immunopathogenesis of Visceral Leishmaniasis Alone or in HIV Coinfection

1Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz, FIOCRUZ, 21040-360 Rio de Janeiro, RJ, Brazil
2Disciplina de Parasitologia, Faculdade de Ciências Médicas, UERJ, 21040-900 Rio de Janeiro, RJ, Brazil

Received 11 June 2012; Accepted 29 July 2012

Academic Editor: Giancarlo Ceccarelli

Copyright © 2012 Joanna Reis Santos-Oliveira and Alda Maria Da-Cruz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Alvar, I. Vélez, C. Bern et al., “Leishmaniasis worldwide and global estimates of this prevalence,” Plos One, vol. 7, no. 5, Article ID e35671, 2012. View at Google Scholar
  2. A. N. S. Maia-Elkhoury, E. H. Carmo, M. L. Sousa-Gomes, and E. Mota, “Analysis of visceral leishmaniasis reports by the capture-recapture method,” Revista de Saúde Pública, vol. 41, no. 6, pp. 931–937, 2007. View at Google Scholar · View at Scopus
  3. K. Kuhls, M. Z. Alam, E. Cupolillo et al., “Comparative microsatellite typing of new world Leishmania infantum reveals low heterogeneity among populations and its recent old world origin,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Saha, S. Mondal, A. Banerjee, J. Ghose, S. Bhowmick, and N. Ali, “Immune responses in kala-azar,” Indian Journal of Medical Research, vol. 123, no. 3, pp. 245–266, 2006. View at Google Scholar · View at Scopus
  5. C. H. N. Costa, G. L. Werneck, D. L. Costa et al., “Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 43, no. 4, pp. 386–392, 2010. View at Google Scholar · View at Scopus
  6. J. Alvar, P. Aparicio, A. Aseffa et al., “The relationship between leishmaniasis and AIDS: the second 10 years,” Clinical Microbiology Reviews, vol. 21, no. 2, pp. 334–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Carvalho, R. S. Teixeira, and W. D. Johnson, “Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection,” Infection and Immunity, vol. 33, no. 2, pp. 498–502, 1981. View at Google Scholar · View at Scopus
  8. C. L. Karp, S. H. El-Safi, T. A. Wynn et al., “In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma,” Journal of Clinical Investigation, vol. 91, no. 4, pp. 1644–1648, 1993. View at Google Scholar · View at Scopus
  9. V. Peruhype-Magalhães, O. A. Martins-Filho, A. Prata et al., “Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-γ and interleukin-10 and low frequency of tumour necrosis factor-α+ monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection,” Clinical and Experimental Immunology, vol. 146, no. 1, pp. 124–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Santos-Oliveira, E. G. Regis, C. R. B. Leal, R. V. Cunha, P. T. Bozza, and A. M. Da-Cruz, “Evidence that lipopolysaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis,” PLoS Neglected Tropical Diseases, vol. 5, no. 7, Article ID e1198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. O. P. Singh, K. Gidwani, R. Kumar et al., “Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood,” Clinical Vaccine Immunology, vol. 19, no. 6, pp. 961–966, 2012. View at Google Scholar
  12. E. M. Carvalho, O. Bacellar, A. Barral, R. Badaro, and W. D. Johnson, “Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated,” Journal of Clinical Investigation, vol. 83, no. 3, pp. 860–864, 1989. View at Google Scholar · View at Scopus
  13. E. M. Carvalho, O. Bacellar, C. Brownell, T. Regis, R. L. Coffman, and S. G. Reed, “Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis,” Journal of Immunology, vol. 152, no. 12, pp. 5949–5956, 1994. View at Google Scholar · View at Scopus
  14. A. Caldas, C. Favali, D. Aquino et al., “Balance of IL-10 and interferon-γ plasma levels in human visceral leishmaniasis: implications in the pathogenesis,” BMC Infectious Diseases, vol. 5, pp. 113–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Goto and M. D. G. Prianti, “Immunoactivation and immunopathogeny during active visceral leishmaniasis,” Revista do Instituto de Medicina Tropical de São Paulo, vol. 51, no. 5, pp. 241–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Barral-Netto, A. Barral, S. B. Santos et al., “Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis,” Journal of Immunology, vol. 147, no. 1, pp. 281–284, 1991. View at Google Scholar · View at Scopus
  17. N. M. Soares, T. P. L. Ferraz, E. G. Nascimento, E. M. Carvalho, and L. Pontes-de-Carvalho, “The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins,” Microbial Pathogenesis, vol. 40, no. 6, pp. 254–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Barral-Netto, R. Badaro, A. Barral et al., “Tumor necrosis factor (cachectin) in human visceral leishmaniasis,” Journal of Infectious Diseases, vol. 163, no. 4, pp. 853–857, 1991. View at Google Scholar · View at Scopus
  19. S. Nylén, R. Maurya, L. Eidsmo, K. Das Manandhar, S. Sundar, and D. Sacks, “Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis,” Journal of Experimental Medicine, vol. 204, no. 4, pp. 805–817, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. C. Douek, M. Roederer, and R. A. Koup, “Emerging concepts in the immunopathogenesis of AIDS,” Annual Review of Medicine, vol. 60, pp. 471–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Brenchley, T. W. Schacker, L. E. Ruff et al., “CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 749–759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Brenchley and D. C. Douek, “Microbial translocation across the GI tract,” Annual Reviews of Immunology, vol. 30, pp. 149–173, 2012. View at Google Scholar
  24. O. J. Harrison and K. J. Maloy, “Innate immune activation in intestinal homeostasis,” Journal of Innate Immunology, vol. 3, no. 6, pp. 585–593, 2011. View at Google Scholar
  25. K. R. Cooke, K. Olkiewicz, N. Erickson, and J. L. M. Ferrara, “The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease,” Journal of Endotoxin Research, vol. 8, no. 6, pp. 440–448, 2002. View at Google Scholar · View at Scopus
  26. C. S. Baba, G. K. Makharia, P. Mathur, R. Ray, S. D. Gupta, and J. C. Samantaray, “Chronic diarrhea and malabsorption caused by Leishmania donovani,” Indian Journal of Gastroenterology, vol. 25, no. 6, pp. 309–310, 2006. View at Google Scholar · View at Scopus
  27. K. G. Luz, F. F. Tuon, M. I. S. Duarte et al., “Cytokine expression in the duodenal mucosa of patients with visceral leishmaniasis,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 43, no. 4, pp. 393–395, 2010. View at Google Scholar · View at Scopus
  28. N. G. Sandler, C. Koh, A. Roque et al., “Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection,” Gastroenterology, vol. 141, no. 4, pp. 1220–1230, 2010. View at Google Scholar
  29. N. Müller and N. Von Allmen, “Recent insights into the mucosal reactions associated with Giardia lamblia infections,” International Journal for Parasitology, vol. 35, no. 13, pp. 1339–1347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Barreto-De-Souza, G. J. Pacheco, A. R. Silva et al., “Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E 2 synthesis,” Journal of Infectious Diseases, vol. 194, no. 6, pp. 846–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. G. F. Cota, M. R. de Sousa, and A. Rabello, “Predictors of visceral leishmaniasis relapse in hiv-infected patients: a systematic review,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Santos-Oliveira, C. B. W. Giacoia-Gripp, P. Alexandrino de Oliveira et al., “High levels of T lymphocyte activation in Leishmania-HIV-1 coinfected individuals despite low HIV viral load,” BMC Infectious Diseases, vol. 10, pp. 358–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Alexandrino-de-Oliveira, J. R. Santos-Oliveira, M. E. C. Dorval et al., “HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil,” Memórias do Instituto Oswaldo Cruz, vol. 105, no. 5, pp. 692–697, 2010. View at Google Scholar · View at Scopus